09.15.25 -- Paying For Lots Of Formulation Work At Your CDMO

Evaluate several studies using the NIH:OVCAR-3 model of human ovarian cancer in the subcutaneous setting in NSG mice with multiple standard agents and vehicles.

A highly concentrated non-aqueous suspension of an IgG1 was developed using a patented platform. Review how the particle size of the mAb impacts the overall behavior of the drug product.

Optimizing delivery along with the formulation is the key to successful clinical outcomes. Research is necessary to understand the relationship between body morphology, injection force, and needle length.

Continuous perfusion manufacturing came about before the technology was mature enough to support it. Now, new data suggests an inflection point in the status quo.

What is the maximum volume of air that can leak into the freeze-dryer without violating the Class 100 / Grade A microbial specifications? A method was developed to measure the exact void volume of a dryer.

Explore project continuity for a pharmaceutical client during restructuring by providing trained on-site experts, implementing operational excellence, and meeting milestones despite senior staff turnover.

Discover how knowledge of microbial processes and process characterization understanding can be used to design targeted BLA programs while managing risks.

Process development experts discuss how advanced cell line development and transposase technology streamline the path to toxicology and first-in-human studies.

These real-world case studies highlight best practices and strategies to optimize bioconjugate drug product tech transfers and supplies in the clinical or commercial phase.

This advanced cell line development technology overcomes production challenges related to the expression and scalability of complex biologics.

Find laboratory services that can support many drug substance or drug product modalities, all product phases, and numerous specialty laboratory services.

Learn how a parallel development service works seamlessly with existing antibody capabilities, helping to accelerate your ADC program and reach market faster.

Review the strategic application of extensive expertise in microbial systems to meet the increasing demand for novel biologics. Cutting-edge capabilities ensure streamlined processes.

Explore how proven expertise and simplified execution with development, filling, and analytical under one roof ensure safe, efficacious products reach patients in need.